Brochure
A breakthrough aptamer-mediated base editing platform for simultaneous knock-in and multiple gene knockout
In this literature review, find out about an application of gene editing that diverges from the conventional paradigm, offering enhanced safety measures and simplifying the process of effecting complex genetic changes in a streamlined workflow.
You will learn about:
- The potential of CAR T cell therapy to combat cancer and barriers to overcome
- How an application of gene editing that diverges from the conventional paradigm can help to address these challenges
- How this approach provides enhanced safety measures and simplifies the process of effecting complex genetic changes in a streamlined workflow
The Pin-point platform technology is available for clinical study and commercialization under a commercial license from Revvity. Pin-point reagents are available for research use only.
To view the full content please answer a few questions
Download Resource
A breakthrough aptamer-mediated base editing platform for simultaneous knock-in and multiple gene knockout